Clinical trial Recruiting at 1 site Interventional Ages 21 and up

Effects of Low Nicotine Cigarettes on Chronic Pain and Cravings

Official title: Targeting Reinforcement Mechanisms for Smoking Cessation Using Very Low Nicotine Content Cigarettes in Individuals With Opioid Use Disorder and Chronic Pain

Run by Duke University · NCT06747871 · Data updated 2026-11-12

This study tests if switching to very low nicotine cigarettes can help people with chronic pain who smoke and are being treated for opioid addiction by reducing their cravings and pain levels.

More Chronic Pain trials

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment60 (estimated)
SponsorDuke University
Academic / other
Locations1 site (Durham, North Carolina)
StatusRecruiting
StartedApril 15, 2025
Main results expectedJuly 30, 2027
Study endsJuly 30, 2027
Registry record updatedJanuary 9, 2026
Trial IDNCT06747871 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 21 and older who smoke at least 10 cigarettes daily and have chronic non-cancer musculoskeletal pain.

Probably not a fit

Patients with cancer-related pain or significant health issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates how switching from normal nicotine content cigarettes to very low nicotine content cigarettes affects cravings, withdrawal symptoms, and pain levels in individuals with chronic pain who smoke daily and are undergoing buprenorphine treatment for opioid use disorder. Participants will be monitored for changes in their pain and smoking behaviors over the course of the intervention. The study aims to provide insights into the potential benefits of reducing nicotine intake for managing chronic pain.

Why it matters

Potential benefit: If successful, this study could help patients with chronic pain reduce their nicotine dependence while managing their pain more effectively.

How similar studies have gone: Other studies have shown promise in using low nicotine cigarettes to aid smoking cessation, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 21+ years who smoke cigarettes daily
* Chronic non-cancer musculoskeletal pain secondary to structural changes (e.g., low back pain, osteoarthritis)
* Have received stable office-based buprenorphine treatment for opioid use disorder for at least 30 days
* Self-report smoking at least 10 cigarettes/day
* Expired breath carbon monoxide (CO) level \>8 ppm
* Have a smartphone capable of running software for ecological momentary assessment
* Open to exploring the possibility of quitting smoking

Exclusion Criteria:

* Pain specifically due to cancer
* Other significant health problems
* Major surgery within the past 6 months or planned surgery within the timeframe of the study
* Current disability litigation
* Use of electronic cigarettes or other non-cigarette tobacco products \> 9 of the past 30 days
* Current use of nicotine replacement therapy or other cessation treatment
* Current daily or near-daily cannabis use
* History of psychotic disorder
* Acute suicidality or current unstable psychiatric disorder
* Positive pregnancy test
* Actively seeking smoking cessation treatment

Where it's running

  • North Pavilion
    Durham, North Carolina, United States
    Recruiting

Study contacts

  • Principal investigator: Maggie Sweitzer, PhD — Duke University
  • Study coordinator: Clinical Research Coordinator
  • Email: ta141@duke.edu
  • Phone: 919-907-9955

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.